UK/Europe

UK/Europe

UK Health Officials Approve Medical Cannabis Products

Sativex and Epidyolex were approved for reimbursement by the NHS for some conditions. But health officials say product costs are too high, and benefits too low, for patients with chronic pain.

UK/Europe

UK’s National Health Service Report Addresses Barriers to Medical Cannabis

The report indicates that the National Institute for Health Research should prioritize research on cannabis-based products in five areas, including chronic pain in children and young people.